NEPH — NEPHROS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1196298 ·
Last close
$2.90
Market Cap
$31.52M
52W High
$6.42
52W Low
$2.66
ADV30
65,961
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 5,622,000 | 3,286,000 | 501,000 | 512,000 | 15,305,000 | 4,546,000 | 2,757,000 |
| Jun 2026 | 6,017,000 | 4,026,000 | 1,213,000 | 1,197,000 | 15,770,000 | 4,697,000 | 3,802,000 |
| Mar 2026 | 5,212,000 | 2,993,000 | 97,000 | 140,000 | 13,794,000 | 4,018,000 | 3,093,000 |
| Dec 2025 | 4,729,000 | 2,761,000 | 18,000 | 62,000 | 13,641,000 | 5,400,000 | 3,439,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-661,000
Investing CF
$0
Financing CF
$284,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.17
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-141,801,000
Inventory
$4,547,000
Receivables
$4,096,000
ST Investments
—
EBIT TTM
$1,710,000
Pretax Income TTM
$1,752,000
Interest Exp TTM
$2,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$20,722,000
EBITDA
$1,768,000
Free Cash Flow
$-1,446,375
Enterprise Value
$29,732,770
Total Cash
$4,697,000
Total Debt
$872,000
Shares Out
10,870,004
Trailing EPS
$0.17
Book Value
$0.96
ROE
16.1%
ROA
7.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 18,789,000 | 1,146,000 | 1,194,000 | 13,641,000 | 3,439,000 | 10,202,000 | 1,645,000 |
| Dec 2024 | 14,162,000 | 6,000 | 74,000 | 11,210,000 | 2,625,000 | 8,585,000 | -492,000 |
| Dec 2023 | 14,238,000 | -1,593,000 | -1,575,000 | 11,861,000 | 3,503,000 | 8,358,000 | 827,000 |
| Dec 2022 | 9,975,000 | -4,335,000 | -7,382,000 | 10,999,000 | 2,118,000 | 5,592,000 | -3,234,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$20,722,000
NetIncome TTM
$1,736,000
OpCashFlow TTM
—
Assets (Latest)
$15,770,000
Forward EPS
$0.21
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NSPR | InspireMD, Inc. | $30.45M | $0.65 | — |
| IDXG | INTERPACE BIOSCIENCES, INC. | $33.24M | $6.00 | — |
| TELA | TELA Bio, Inc. | $34.44M | $0.76 | — |
| XTNT | Xtant Medical Holdings, Inc. | $28.79M | $0.21 | — |
| ADGM | Adagio Medical Holdings, Inc. | $36.65M | $1.65 | — |
News headlines (Yahoo Finance, 1h cache)
Nephros (NEPH) Q3 2026 Earnings Call Transcript
2026-11-06 17:50 · Yahoo
Nephros, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Nephros Inc. (NEPH) Tops Q3 Earnings and Revenue Estimates
2026-11-06 00:00 · Yahoo
Nephros Announces Strong Third Quarter 2026 Financial Results
2026-11-05 21:10 · Yahoo
Nephros Schedules Third Quarter 2026 Financial Results Conference Call
2026-10-29 20:30 · Yahoo
Nephros (NEPH) Q2 2026 Earnings Call Transcript
2026-08-13 11:42 · Yahoo
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...
2026-08-07 05:11 · Yahoo
Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
2026-08-06 20:10 · Yahoo
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
2026-07-20 11:00 · Yahoo
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
2026-06-16 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.